184 related articles for article (PubMed ID: 35492260)
21. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
22. Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients.
Len P; Iskakova G; Sautbayeva Z; Kussanova A; Tauekelova AT; Sugralimova MM; Dautbaeva AS; Abdieva MM; Ponomarev ED; Tikhonov A; Bekbossynova MS; Barteneva NS
Front Cardiovasc Med; 2022; 9():794092. PubMed ID: 35360017
[TBL] [Abstract][Full Text] [Related]
23. Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria.
Omoregie R; Osakue SI; Ihemeje V; Omokaro EU; Ogeferet HO
West Indian Med J; 2009 Nov; 58(5):437-40. PubMed ID: 20441062
[TBL] [Abstract][Full Text] [Related]
24. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
25. Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status.
Thulasi Raman R; Manimaran D; Rachakatla P; Bharathi K; Afroz T; Sagar R
J Clin Diagn Res; 2016 May; 10(5):EC04-6. PubMed ID: 27437222
[TBL] [Abstract][Full Text] [Related]
26. Asymptomatic thyroid dysfunction in human immunodeficiency virus-1-infected subjects.
Emokpae MA; Akinnuoye IM
J Lab Physicians; 2018; 10(2):130-134. PubMed ID: 29692575
[TBL] [Abstract][Full Text] [Related]
27. The Prevalence of HIV-infected Patients with Virological Suppression but a CD4
Wu Z; Yang C; Ma Y; Wang Y; Zhang Z; Liu Z; Li P; Guo H; Jin Y
AIDS Rev; 2022 Mar; 24(1):16-23. PubMed ID: 34153977
[TBL] [Abstract][Full Text] [Related]
28. Anemia and thrombocytopenia in the cohort of HIV-infected adults in northwest Ethiopia: a facility-based cross-sectional study.
Deressa T; Damtie D; Workineh M; Genetu M; Melku M
EJIFCC; 2018 Apr; 29(1):36-47. PubMed ID: 29765285
[TBL] [Abstract][Full Text] [Related]
29. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
30. The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.
Wu L; Jin C; Bai S; Davies H; Rao H; Liang Y; Wu N
J Res Med Sci; 2015 Feb; 20(2):127-32. PubMed ID: 25983763
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Anemia and Immunological Markers in HIV-Infected Patients on Highly Active Antiretroviral Therapy in Northeastern Nigeria.
Denue BA; Kida IM; Hammagabdo A; Dayar A; Sahabi MA
Infect Dis (Auckl); 2013; 6():25-33. PubMed ID: 24847174
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
Muhammad S; Sani MU; Okeahialam BN
Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
[TBL] [Abstract][Full Text] [Related]
33. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
Zhang X; Yang X; Jiao H; Liu X
Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of anemia and its associated factors in human immuno deficiency virus infected adult individuals in Ethiopia. A systematic review and meta-analysis.
Negesse A; Getaneh T; Temesgen H; Taddege T; Jara D; Abebaw Z
BMC Hematol; 2018; 18():32. PubMed ID: 30459953
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
36. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of home-based HIV counseling and testing on reducing stigma and risky sexual behavior among adults and adolescents: A systematic review and meta-analyses.
Feyissa GT; Lockwood C; Munn Z
JBI Database System Rev Implement Rep; 2015 Jul; 13(6):318-72. PubMed ID: 26455755
[TBL] [Abstract][Full Text] [Related]
38. Coagulation abnormalities in patients with chronic liver disease in Pakistan.
Siddiqui SA; Ahmed M; Ghani MH; Memon MA; Mustafa G; Ghori MA
J Pak Med Assoc; 2011 Apr; 61(4):363-7. PubMed ID: 21465974
[TBL] [Abstract][Full Text] [Related]
39. Hematological Abnormalities of Adult HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: A Cross-Sectional Study.
Damtie S; Workineh L; Kiros T; Eyayu T; Tiruneh T
HIV AIDS (Auckl); 2021; 13():477-484. PubMed ID: 33976573
[TBL] [Abstract][Full Text] [Related]
40. Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis.
Wang Y; Song Z; Wei X; Yuan H; Xu X; Liang H; Wen H
PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010489. PubMed ID: 35714138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
